Val, Hungary

Márk Molnár

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Les Laboratoires Servier, Vernalis (R&D) Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Márk Molnár. Retrieved from https://idiyas.com/inventor/márk-molnár

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Márk Molnár

Introduction

Márk Molnár is a notable inventor based in Vál, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative research and development efforts. His work has led to the creation of valuable compounds that have potential applications in medical treatments.

Latest Patents

Márk Molnár holds a patent for "3,6-Diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents." This patent highlights his focus on developing compounds that can induce apoptosis, which is crucial in cancer treatment and other medical applications. He has 1 patent to his name, showcasing his inventive capabilities.

Career Highlights

Throughout his career, Márk has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Les Laboratoires Servier and Vernalis (R&D) Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Márk has collaborated with various professionals in his field, including his coworker Tibor Novák. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Márk Molnár's contributions to the field of pharmaceuticals through his patent and career experiences demonstrate his commitment to innovation. His work continues to impact the industry positively, paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…